AEON Biopharma, Inc. (AEON) — Financial Flexibility Index
AEON Biopharma, Inc. (AEON) has a Financial Flexibility Index of -0.09x as of September 2025. Free cash flow of $-2.60 Million (operating CF $-2.60 Million minus capex $0.00) represents 0% of total liabilities ($28.61 Million). Also explore how fast is AEON Biopharma, Inc. growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AEON Biopharma, Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for AEON Biopharma, Inc. across 6 annual periods. Check AEON asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for AEON Biopharma, Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for AEON Biopharma, Inc.. For the full company profile including market capitalisation, see AEON Biopharma, Inc. market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.64x | $-20.29 Million | $-20.29 Million | $31.71 Million | ▼ -113.9% |
| 2023 | -0.30x | $-47.83 Million | $-47.83 Million | $159.89 Million | ▼ -138.4% |
| 2022 | -0.13x | $-35.28 Million | $-35.58 Million | $281.19 Million | ▼ -2.2% |
| 2021 | -0.12x | $-28.26 Million | $-28.43 Million | $230.26 Million | ▼ -196.5% |
| 2020 | -0.04x | $-9.29 Million | $-9.46 Million | $224.45 Million | ▲ +82.7% |
| 2019 | -0.24x | $-43.03 Million | $-44.73 Million | $180.22 Million | — |